Rebecca Taub

Company: Madrigal Pharmaceuticals
Job title: Founder, Director & Chief Medical Officer, President R&D
Seminars:
Panel Discussion & Q&A: Using AI-Powered NASH Pathology to Accelerate NASH Drug Development: Where Are We Today & Where Are We Headed? 5:35 pm
Discussing latest advancements of AI-powered pathology to address the most immediate issues with variability in CRN scoring for enrollment and endpoints to advance NASH drug development Tackling numerous challenges that impact trial success including inter-reader variability from manual reads, trial delays due to challenging patient enrollment, and additional costs or delays due to inconsistent performance…Read more
day: Accelerating NASH Drug Development with AI-Powered NASH Pathology